Siemens Healthineers plans to halve the number of diagnostic platforms it offers in coming years as it seeks to overcome supply chain and other external challenges.
In its Q4 earning announcement today, the German medtech giant said the €1.5-billion-a-year Diagnostics business faces procurement and logistics challenges. Also, there are foreign currency headwinds and COVID-related lockdowns in China.
Siemens Healthineers recently started the controlled rollout of its CI 1900 low-to-mid-volume analyzer in Europe.
“We will undertake significant measures to reduce complexity by reducing the number of our platforms by more than 50% over time following the CI 1900 platform launch,” CEO Bernd Montag said during the company’s earnings call today, transcribed by Seeking Alpha.
“Our portfolio complexity has been a particular burden in the current challenging environment and supply chain environment. … We will streamline our sup…